KDM1A and neoplasm: SP-2577 reversibly inhibits KDM1A demethylation and has been recently found to promote anti tumor immunity in mutated ovarian cancer cells in vitro and has also been found to inhibit growth in Ewing Sarcoma xenografts (Salarius Pharmaceuticals, Inc., 2020; Soldi et al., 2020).